Fresh Tracks Therapeutics, Inc. Profile Avatar - Palmy Investing

Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company dev…

Biotechnology
US, Boulder [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of FRTX's Analysis
CIK: 819050 CUSIP: - ISIN: US10802T2042 LEI: - UEI: -
Secondary Listings
FRTX has no secondary listings inside our databases.